1. Academic Validation
  2. Interaction potential of etravirine with drug transporters assessed in vitro

Interaction potential of etravirine with drug transporters assessed in vitro

  • Antimicrob Agents Chemother. 2011 Mar;55(3):1282-4. doi: 10.1128/AAC.01527-10.
Nadine Cécile Luise Zembruski 1 Walter Emil Haefeli Johanna Weiss
Affiliations

Affiliation

  • 1 Department of Clinical Pharmacology and Pharmacoepidemiology, University Hospital Heidelberg, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
Abstract

Etravirine is a novel nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) for the treatment of HIV-1 infections. ABC transporters potentially mediate clinically relevant drug-drug interactions. We assessed substrate characteristics and the inhibitory and inductive potential of etravirine on ABC transporters. Etravirine did not inhibit P-gp/ABCB1 and was not transported by the tested ABC transporters but was a potent inhibitor of BCRP/ABCG2. Etravirine induced several ABC transporters, especially BCRP/ABCG2. These data demonstrate that etravirine has the potential for drug-drug interactions by modulation of expression and function of several ABC transporters.

Figures